Integral Diagnostics Ltd (IDX) - Total Liabilities

Latest as of June 2025: AU$732.53 Million AUD ≈ $518.31 Million USD

Based on the latest financial reports, Integral Diagnostics Ltd (IDX) has total liabilities worth AU$732.53 Million AUD (≈ $518.31 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Integral Diagnostics Ltd - Total Liabilities Trend (2012–2025)

This chart illustrates how Integral Diagnostics Ltd's total liabilities have evolved over time, based on quarterly financial data. See IDX working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Integral Diagnostics Ltd Competitors by Total Liabilities

The table below lists competitors of Integral Diagnostics Ltd ranked by their total liabilities.

Company Country Total Liabilities
HeNan Splendor Science & Technology Co Ltd
SHE:002296
China CN¥802.69 Million
Esso S.A.F.
PA:ES
France €2.75 Billion
ZimVie Inc
NASDAQ:ZIMV
USA $345.42 Million
HELLOFRESH UNSP.ADS/025
F:HFG0
Germany €1.61 Billion
Chengdu Screen Micro-Electronics Co. Ltd. A
SHG:688053
China CN¥125.67 Million
Shanghai HiTech Control System
SHE:002184
China CN¥1.75 Billion
Tae Kwang Corporation
KQ:023160
Korea ₩71.20 Billion
Cachet Pharmaceutical Co Ltd
SHE:002462
China CN¥6.02 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Integral Diagnostics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see IDX stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.68 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.06 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.51 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Integral Diagnostics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Integral Diagnostics Ltd (2012–2025)

The table below shows the annual total liabilities of Integral Diagnostics Ltd from 2012 to 2025.

Year Total Liabilities Change
2025-06-30 AU$732.53 Million
≈ $518.31 Million
+65.52%
2024-06-30 AU$442.57 Million
≈ $313.15 Million
-5.02%
2023-06-30 AU$465.96 Million
≈ $329.70 Million
+6.93%
2022-06-30 AU$435.77 Million
≈ $308.34 Million
+8.90%
2021-06-30 AU$400.16 Million
≈ $283.14 Million
+11.60%
2020-06-30 AU$358.58 Million
≈ $253.72 Million
+91.30%
2019-06-30 AU$187.45 Million
≈ $132.63 Million
+83.57%
2018-06-30 AU$102.11 Million
≈ $72.25 Million
+2.08%
2017-06-30 AU$100.03 Million
≈ $70.78 Million
+2.93%
2016-06-30 AU$97.19 Million
≈ $68.76 Million
-14.90%
2015-06-30 AU$114.20 Million
≈ $80.80 Million
+2038.51%
2014-06-30 AU$5.34 Million
≈ $3.78 Million
+4854461.82%
2013-06-30 AU$110.00
≈ $77.83
-99.98%
2012-06-30 AU$501.00K
≈ $354.49K
--

About Integral Diagnostics Ltd

AU:IDX Australia Diagnostics & Research
Market Cap
$535.65 Million
AU$757.04 Million AUD
Market Cap Rank
#12022 Global
#309 in Australia
Share Price
AU$2.03
Change (1 day)
-1.93%
52-Week Range
AU$2.00 - AU$3.05
All Time High
AU$5.00
About

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as … Read more